Near patient blood glucose monitoring

Michael Laposata, K. B. Lewandrowski

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

This report describes the quality control and quality assurance programs for bedside glucometry at our institution. From our 3-year experience, a regular schedule of inspections is necessary for maintenance of high-quality bedside glucose testing. The most common violation of quality control/quality assurance in bedside glucometry in our institution was the failure to perform regular proficiency testing, in which one random patient's bedside capillary blood glucose value during each inspection period was compared to his or her venous plasma or serum glucose value obtained from the central laboratory. Failure to perform instrument maintenance and document operator certification were the next most common violations of quality control/quality assurance in our bedside glucometry program. Regarding the cost analysis for bedside glucometry, we conclude that bedside glucose testing is not inherently more expensive than testing performed within the clinical laboratory. The increased cost of bedside glucometry over laboratory testing can be significantly minimized by involvement of a limited number of health care workers and performance of bedside glucometry only on clinical units where testing is required more than five times per day.

Original languageEnglish (US)
Pages (from-to)926-928
Number of pages3
JournalArchives of Pathology and Laboratory Medicine
Volume119
Issue number10
StatePublished - 1995
Externally publishedYes

Fingerprint

Quality Control
Blood Glucose
Glucose
Costs and Cost Analysis
Certification
Appointments and Schedules
Maintenance
Delivery of Health Care
Serum
Point-of-Care Testing

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Medical Laboratory Technology

Cite this

Near patient blood glucose monitoring. / Laposata, Michael; Lewandrowski, K. B.

In: Archives of Pathology and Laboratory Medicine, Vol. 119, No. 10, 1995, p. 926-928.

Research output: Contribution to journalArticle

Laposata, M & Lewandrowski, KB 1995, 'Near patient blood glucose monitoring', Archives of Pathology and Laboratory Medicine, vol. 119, no. 10, pp. 926-928.
Laposata, Michael ; Lewandrowski, K. B. / Near patient blood glucose monitoring. In: Archives of Pathology and Laboratory Medicine. 1995 ; Vol. 119, No. 10. pp. 926-928.
@article{d83011a0a58844b89ccb650fe527be7c,
title = "Near patient blood glucose monitoring",
abstract = "This report describes the quality control and quality assurance programs for bedside glucometry at our institution. From our 3-year experience, a regular schedule of inspections is necessary for maintenance of high-quality bedside glucose testing. The most common violation of quality control/quality assurance in bedside glucometry in our institution was the failure to perform regular proficiency testing, in which one random patient's bedside capillary blood glucose value during each inspection period was compared to his or her venous plasma or serum glucose value obtained from the central laboratory. Failure to perform instrument maintenance and document operator certification were the next most common violations of quality control/quality assurance in our bedside glucometry program. Regarding the cost analysis for bedside glucometry, we conclude that bedside glucose testing is not inherently more expensive than testing performed within the clinical laboratory. The increased cost of bedside glucometry over laboratory testing can be significantly minimized by involvement of a limited number of health care workers and performance of bedside glucometry only on clinical units where testing is required more than five times per day.",
author = "Michael Laposata and Lewandrowski, {K. B.}",
year = "1995",
language = "English (US)",
volume = "119",
pages = "926--928",
journal = "Archives of Pathology and Laboratory Medicine",
issn = "0003-9985",
publisher = "College of American Pathologists",
number = "10",

}

TY - JOUR

T1 - Near patient blood glucose monitoring

AU - Laposata, Michael

AU - Lewandrowski, K. B.

PY - 1995

Y1 - 1995

N2 - This report describes the quality control and quality assurance programs for bedside glucometry at our institution. From our 3-year experience, a regular schedule of inspections is necessary for maintenance of high-quality bedside glucose testing. The most common violation of quality control/quality assurance in bedside glucometry in our institution was the failure to perform regular proficiency testing, in which one random patient's bedside capillary blood glucose value during each inspection period was compared to his or her venous plasma or serum glucose value obtained from the central laboratory. Failure to perform instrument maintenance and document operator certification were the next most common violations of quality control/quality assurance in our bedside glucometry program. Regarding the cost analysis for bedside glucometry, we conclude that bedside glucose testing is not inherently more expensive than testing performed within the clinical laboratory. The increased cost of bedside glucometry over laboratory testing can be significantly minimized by involvement of a limited number of health care workers and performance of bedside glucometry only on clinical units where testing is required more than five times per day.

AB - This report describes the quality control and quality assurance programs for bedside glucometry at our institution. From our 3-year experience, a regular schedule of inspections is necessary for maintenance of high-quality bedside glucose testing. The most common violation of quality control/quality assurance in bedside glucometry in our institution was the failure to perform regular proficiency testing, in which one random patient's bedside capillary blood glucose value during each inspection period was compared to his or her venous plasma or serum glucose value obtained from the central laboratory. Failure to perform instrument maintenance and document operator certification were the next most common violations of quality control/quality assurance in our bedside glucometry program. Regarding the cost analysis for bedside glucometry, we conclude that bedside glucose testing is not inherently more expensive than testing performed within the clinical laboratory. The increased cost of bedside glucometry over laboratory testing can be significantly minimized by involvement of a limited number of health care workers and performance of bedside glucometry only on clinical units where testing is required more than five times per day.

UR - http://www.scopus.com/inward/record.url?scp=0029584540&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029584540&partnerID=8YFLogxK

M3 - Article

C2 - 7487393

AN - SCOPUS:0029584540

VL - 119

SP - 926

EP - 928

JO - Archives of Pathology and Laboratory Medicine

JF - Archives of Pathology and Laboratory Medicine

SN - 0003-9985

IS - 10

ER -